Automation News and Research

RSS

How cohesin mechanics and nanotracker tech are redefining DNA research

Discover how cohesin mechanics and nanotracker technology are transforming DNA research in this Bruker webinar.

From Bruker Nano Surfaces and Metrology 19 Aug 2025

Redefining BLI: Near-SPR performance built for real-world biologics

Discover how the next-generation technology delivers near-SPR performance tailored for the complexities of real-world biologics.

From Sartorius 19 Aug 2025

Study investigates aging-related mechanisms in idiopathic pulmonary fibrosis using AI approaches

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by the excessive accumulation of extracellular matrix components, leading to a gradual decline in lung function and, ultimately, respiratory failure.

13 Aug 2025

RSNA AI Challenge models show excellent performance for detecting breast cancers on mammograms

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while maintaining low recall rates, according to a study published today in Radiology, the premier journal of the RSNA.

12 Aug 2025

Right shoring your supply chain in Life Sciences: Balancing cost, risk & resilience

Discover expert insights on right shoring supply chains in medical and life sciences. Learn how cost, risk, regionalization, and automation shape long term resilience.

From Ascential Medical & Life Sciences 12 Aug 2025

LabConnect deploys Sapio LIMS across global operations

Sapio Sciences, the science-aware™ lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect.

From Sapio Sciences 7 Aug 2025

ChatGPT helps speed up patient screening for clinical trials

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.

1 Aug 2025

Novel insights from lymphoid structures: Lessons from colorectal cancer research

Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.

From TissueGnostics 31 Jul 2025

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Discover how twin screw granulation enables continuous, solvent free drug amorphization—expert insights from Thermo Fisher Scientific’s Maggie Richter.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 30 Jul 2025

AI-powered blood test improves early Lyme disease detection

Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard - and that could translate to vastly improved patient outcomes.

28 Jul 2025

Optimal Group joins SciY

The SciY business today announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite, creating a single, vendor-agnostic software and automation platform that connects molecular research and development, quality control labs, and full-scale biopharma and specialty chemicals manufacturing environments.

From SciY 22 Jul 2025

OneTouch-PAT system detects breast cancer in under a minute without compression

A breast scan for detecting cancer takes less than a minute using an experimental system that combines photoacoustic and ultrasound imaging, according to a study in IEEE Transactions on Medical Imaging.

12 Jul 2025

AI and robotics transform precision in medical needle procedures

Imagine a physician attempting to reach a cancerous nodule deep within a patient's lung – a target the size of a pea, hidden behind a maze of critical blood vessels and airways that shift with every breath.

10 Jul 2025

SPT Labtech and Semarion collaborate to advance automated cell-based assay workflows

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs.

9 Jul 2025

Understanding the human brain architecture through gene coexpression analysis

In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive to computational neuroscientist and his groundbreaking contributions to understanding the human brain's cellular and molecular architecture through gene coexpression analysis.

8 Jul 2025

New study finds UK mums-to-be miss out on key nutrients

A new British Nutrition Foundation review finds that most UK women of reproductive age fall short of key nutrients before and during pregnancy, with teens and low-income groups most affected. The paper urges targeted, consistent guidance and greater support for healthy weight, supplementation, and plant-based diets.

7 Jul 2025

Intelligent, Scalable, Precise: How n6 Is Transforming NGS Library Prep

In this interview, the team at n6 discusses their groundbreaking iconPCR thermocycler and its impact on laboratory automation, NGS data quality, and real-time control in life sciences.

From n6 7 Jul 2025

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers.

4 Jul 2025

Shaping the future of lab automation through AI and robotics

Discover how Chemspeed is revolutionizing lab automation with AI-driven workflows, modular robotics, and more

From Bruker BioSpin Group 3 Jul 2025

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical trial (NCT06414460) to evaluate ISM3412, a potentially best-in-class, AI-empowered MAT2A inhibitor with novel structure, in patients with locally advanced and metastatic solid tumors.

27 Jun 2025